ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,940.46
      -0.39%
      US Tech 100
      20,740.40
      -0.67%
      Dow Jones
      42,677.24
      -0.27%
      Brent Oil
      65.105
      0.15%
      Bitcoin
      106,564.05
      0.90%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Matinas Biopharma Holdings Inc (MTNB)

      7. Matinas Biopharma Holdings Inc (MTNB) News

      MTNB

      Matinas Biopharma (MTNB)

      Matinas Biopharma Holdings Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:MTNB
      DateTimeSourceHeadlineSymbolCompany
      05/13/20259:19AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:MTNBMatinas Biopharma Holdings Inc
      05/05/20258:49AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:MTNBMatinas Biopharma Holdings Inc
      05/02/20255:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:MTNBMatinas Biopharma Holdings Inc
      05/02/20255:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MTNBMatinas Biopharma Holdings Inc
      04/30/202512:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:MTNBMatinas Biopharma Holdings Inc
      04/29/20255:15PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:MTNBMatinas Biopharma Holdings Inc
      04/29/20255:07PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:MTNBMatinas Biopharma Holdings Inc
      04/22/20255:28PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:MTNBMatinas Biopharma Holdings Inc
      04/15/20255:18PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:MTNBMatinas Biopharma Holdings Inc
      04/10/20255:14PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:MTNBMatinas Biopharma Holdings Inc
      04/10/20254:45PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:MTNBMatinas Biopharma Holdings Inc
      04/10/20251:54PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:MTNBMatinas Biopharma Holdings Inc
      04/10/20251:44PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:MTNBMatinas Biopharma Holdings Inc
      04/08/20255:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MTNBMatinas Biopharma Holdings Inc
      04/04/20255:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MTNBMatinas Biopharma Holdings Inc
      03/31/20255:15PMEdgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:MTNBMatinas Biopharma Holdings Inc
      03/14/20255:20PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MTNBMatinas Biopharma Holdings Inc
      03/11/20257:01AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MTNBMatinas Biopharma Holdings Inc
      03/11/20257:00AMGlobeNewswire Inc.Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of DirectorsAMEX:MTNBMatinas Biopharma Holdings Inc
      03/03/20255:25PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:MTNBMatinas Biopharma Holdings Inc
      02/28/20254:58PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:MTNBMatinas Biopharma Holdings Inc
      02/25/20256:35PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:MTNBMatinas Biopharma Holdings Inc
      02/21/20255:15PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:MTNBMatinas Biopharma Holdings Inc
      02/21/20253:11PMEdgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipAMEX:MTNBMatinas Biopharma Holdings Inc
      02/21/20253:07PMEdgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipAMEX:MTNBMatinas Biopharma Holdings Inc
      02/19/20254:05PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:MTNBMatinas Biopharma Holdings Inc
      02/19/20252:22PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:MTNBMatinas Biopharma Holdings Inc
      02/13/20255:20PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MTNBMatinas Biopharma Holdings Inc
      02/13/20255:00PMGlobeNewswire Inc.Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of DirectorsAMEX:MTNBMatinas Biopharma Holdings Inc
      02/11/20255:10PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MTNBMatinas Biopharma Holdings Inc
       Showing the most relevant articles for your search:AMEX:MTNB